Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Stefania, Tringali"'
Autor:
Marika Porrazzo, Tiziana Moscato, Giuseppe Sapienza, Fabrizio Accardi, Caterina Patti, Clotilde Cangialosi, Carmelo Costanza, Roberto Bono, Stefania Tringali, Cristina Rotolo, Emilia Gigliotta, Andrea Rizzuto, Manuela Giuseppa Ingrascè, Giulia Butera, Laura Di Noto, Alessandra Santoro, Anna Marfia, Cirino Botta, Sergio Siragusa, Massimo Martino, Luca Castagna
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/04484ba6ad5f477db2f79aa6aa2ed786
Autor:
Giuseppe Sapienza, Marta Castronovo, Stefania Tringali, Roberto Bono, Cristina Rotolo, Antonino Mulè, Valeria Calafiore, Caterina Patti, Cecilia Agueli, Valentina Randazzo, Alessandra Santoro, Domenica Matranga, Luca Castagna
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionAcute myeloid leukemia (AML) relapse is the main cause of death after allogeneic stem cell transplant (allo-SCT). In AML FLT3+, it was shown that Sorafenib used as maintenance therapy after allo-SCT, significantly reduces the risk of rela
Externí odkaz:
https://doaj.org/article/312b6091ee5e447aba2169519861a944
Autor:
Luca Castagna, Stefania Tringali, Giuseppe Sapienza, Roberto Bono, Rosario Di Maggio, Aurelio Maggio
Publikováno v:
Thalassemia Reports, Vol 13, Iss 2, Pp 122-130 (2023)
Allogeneic stem cell transplantation remains the only therapy for congenital, severe haemoglobinopathies that is able to reverse the pathological phenotype. In the severe form of thalassemia, regular transfusions are needed early in life. This popula
Externí odkaz:
https://doaj.org/article/dcca6b75f44a4041961a13155e33cc5c
Autor:
Roberto Bono, Giuseppe Sapienza, Stefania Tringali, Cristina Rotolo, Caterina Patti, Antonino Mulè, Valeria Calafiore, Alessandra Santoro, Luca Castagna
Publikováno v:
Cells, Vol 13, Iss 9, p 755 (2024)
Refractory acute myeloid leukaemia is very difficult to treat and represents an unmet clinical need. In recent years, new drugs and combinations of drugs have been tested in this category, with encouraging results. However, all treated patients relap
Externí odkaz:
https://doaj.org/article/d161abaec8d14aa280513d7f926a558a
Autor:
Luca Castagna, Roberto Bono, Stefania Tringali, Giuseppe Sapienza, Alessandra Santoro, Alessandro Indovina, Vittoria Tarantino, Laura Di Noto, Aurelio Maggio, Caterina Patti
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Chimeric antigen receptor T (CAR-T) cells are a treatment option for patients with relapse/refractory (R/R) non-Hodgkin lymphoma (NHL), acute lymphoid leukemia and multiple myeloma. To date, diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma
Externí odkaz:
https://doaj.org/article/c647f67729a846b480e3c2457fbd7598
Autor:
Massimo Martino, Annalisa Pitino, Mercedes Gori, Benedetto Bruno, Alessandra Crescimanno, Vincenzo Federico, Alessandra Picardi, Stefania Tringali, Claudia Ingrosso, Paola Carluccio, Domenico Pastore, Gerardo Musuraca, Annalisa Paviglianiti, Adriana Vacca, Bianca Serio, Gabriella Storti, Nicola Mordini, Salvatore Leotta, Michele Cimminiello, Lucia Prezioso, Barbara Loteta, Anna Ferreri, Fabrizia Colasante, Emanuela Merla, Luisa Giaccone, Alessandro Busca, Maurizio Musso, Renato Scalone, Nicola Di Renzo, Serena Marotta, Patrizio Mazza, Pellegrino Musto, Immacolata Attolico, Carmine Selleri, Filippo Antonio Canale, Marta Pugliese, Giovanni Tripepi, Gaetana Porto, Giovanni Martinelli, Angelo Michele Carella, Claudio Cerchione
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Despite effective treatments, cytomegalovirus (CMV) continues to have a significant impact on morbidity and mortality in allogeneic stem cell transplant (allo-SCT) recipients. This multicenter, retrospective, cohort study aimed to evaluate the reprod
Externí odkaz:
https://doaj.org/article/e505e90b69714fdf86208ecf0841bd1a
Autor:
Uros Markovic, Ernesto Vigna, Francesco Grimaldi, Giulia Palazzo, Antonio M. Risitano, Massimo Martino, Maria Cristina Pirosa, Giuseppe Milone, Stefania Stella, Giovanni Pisapia, Angelo Curto Pelle, Raffaele Palmieri, Luca Scalise, Francesco Di Raimondo, Stefania Tringali, Salvatore Leotta, Giulio Antonio Milone, Valerio Leotta, Fausto Palmieri, Paola Carluccio, Mary Ann Di Giorgio, Giorgina Specchia, Anna Bulla, Mario Annunziata
Publikováno v:
Annals of Hematology. 100:1743-1753
The experience of third-generation tyrosine kinase inhibitor ponatinib treatment in Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph'+ ALL) patients post-allogeneic transplantation is limited. We retrospectively collected data on 25
Autor:
Salvatore Leotta, Andrea Duminuco, Antonino Mulè, Stefania Tringali, Elisa Mauro, Calogero Vetro, Cinzia Maugeri, Marina Parisi, Bruno Garibaldi, Nicola Di Renzo, Claudia Romano, Domenico Pastore, Massimo Gentile, Ernesto Vigna, Carmine Selleri, Giuseppe Milone, Uros Markovic
Publikováno v:
Blood. 140:11854-11855
Autor:
Giuseppe Longo, Vanessa Innao, Emilia Cotzia, Valeria Calafiore, Stefania Tringali, Donato Mannina, Enrica Antonia Martino, Maurizio Musso, Bruno Garibaldi, Ugo Consoli, Vittorio Del Fabro, Salvatore Innorcia, Clotilde Cangialosi, Concetta Conticello, Cinzia Maugeri, Marina Parisi, Alessandra Romano, Melania Carlisi, Massimo Poidomani, Giuseppe Sapienza, Francesco Di Raimondo
Background: Triplet-based lenalidomide plus dexamethasone (Rd) combinations have become the new standard of care for early relapse and refractory multiple myeloma (RRMM). Carfilzomib is a novel selective proteasome inhibitor (PI) with high efficacy i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5e0929ff902caf166eb59c7ed1c9722
http://hdl.handle.net/11570/3171814
http://hdl.handle.net/11570/3171814
Autor:
Maria Pampinella, Rosanna Scimè, Ignazio Majolino, Stefania Tringali, Vasta S, Alessandra Santoro, Maria Assunta Marino
Publikováno v:
European Journal of Haematology. 53:1-5
Experimental and clinical data suggest that Ph-negative myeloid progenitor cells are present, albeit suppressed, in the bone marrow of chronic myeloid leukemia (CML) patients. These residual Ph-negative cells might, in certain circumstances, regain t